Oakridge International Ltd (OAK) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Oakridge International Ltd stock A$0.05, price A$0.06, that is 21.3% below the price, quality 55 out of 100. Rating: overvalued. Calculated from audited financials with 17 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range A$0.0470 – A$0.4000 · fair‑value band A$0.0400 – A$0.0640 · the A$0.0610 price screens above the A$0.0480 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Oakridge International in your weekly email
Every Wednesday you see whether Oakridge International is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Oakridge International Limited, together with its subsidiaries, engages in the sale of professional healthcare technology equipment and solutions to healthcare facilities.
Show moreShow less
The company develops and distributes a range of nurse call hardware and software solutions for use in multiple healthcare sectors, including hospitals, aged care, disability care, and supported independent living facilities. It is also involved in the development of Internet of Things technology.
The company was formerly known as Xped Limited and changed its name to Oakridge International Limited in April 2021. Oakridge International Limited is based in Adelaide, Australia.
Stock analysis
Oakridge International Ltd (OAK) currently trades at A$0.0610, while our model-based Fair Value estimate is A$0.0480, 21% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of A$0.1600 per share, and 8 of the 17 models we run sit above the A$0.0610 price.
Bear case: the DCF Models group reads lowest at A$0.0400, and 9 of the 17 models stay below the price. Data coverage for this calculation is low.
Scenario range: A$0.0400 (bear) to A$0.0640 (bull), the price of A$0.0610 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 55/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Oakridge International Ltd reported revenue of A$3.1M in FY2025 versus A$497K in FY2021, a compound +58.0%/yr. Reported net income was A$109K in FY2025.
Key figures
Market cap A$2.0M (≈ $1.3M) Micro · P/S ratio 0.74 · Net margin 3.5% · Return on equity 9.7% · Return on assets (EBIT) −32.5% (5-year average) · Operating margin −2.9% · Revenue (TTM) A$3.4M · Revenue growth (YoY) +24.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 30 out of 100 (low confidence).
What moves the price
The share trades about 39% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 3% fair-value upside, at −21%, OAK screens richer than that median.
Fair Value models
BearA$0.0400Fair Value A$0.0480BullA$0.0640
Price A$0.0610 · Downside -21.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.61/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+38.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+41.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+27.8%
Start year 2020 (pandemic)
Revenue growth 11 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.1%
’14
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−40.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−40.1%
Dividend (yield on the price)0.0%
Profit margin 2019 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−133% → −7%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+23.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Australia: IMF forecast 3.0% a year to 2030, 2.9% from 2016 to 2025) that is about +20.2% a year for the price.
Compare Oakridge International Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 117 stocks
Beats the industry median on 7/11 measures
Overall it ranks above its industry peers.
Valuation
Quality Score55 · Below median
Fair Value upside−21.3% · Above median
Profitability
Return on equity (12 months)9.7% · Above median
Return on assets5.1% · Above median
Net margin (12 months)3.2% · Below median
Operating margin (12 months)−2.9% · Below median
Growth and dividend
Revenue growth (quarter YoY)24.7% · Top 25%
Valuation Multiplesvs Health Information Services median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Oakridge International Ltd Fair Value". https://www.fairvalue-calculator.com/stock/OAK
Frequently asked questions
Is Oakridge International Ltd (OAK) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of A$0.0480 versus a price of A$0.0610, about 21% lower (overvalued).
What is the fair value of OAK?
Our model-based fair value for Oakridge International Ltd is A$0.0480 (as of Nov 8, 2026), built from audited fundamentals. The current price: A$0.0610.
What is the quality score of OAK?
Oakridge International Ltd has a Quality Score of 55/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Oakridge International Ltd (OAK)?
Our model-based price target is the fair value of A$0.0480 (as of Nov 8, 2026) from 17 valuation models. Cautious scenario A$0.0400, optimistic scenario A$0.0640. It is a calculation from audited fundamentals, not an analyst target.
What is the Oakridge International Ltd stock forecast for 2026?
Our models put fair value at A$0.0480, about 21% lower versus a price of A$0.0610 (overvalued). Cautious scenario A$0.0400, optimistic scenario A$0.0640. The calculation is refreshed regularly with new filings.
What is the revenue of Oakridge International Ltd (OAK)?
Oakridge International Ltd reported trailing-twelve-month revenue of about A$3.4M (latest available figure, as of Nov 8, 2026).
What growth is priced into Oakridge International Ltd (OAK)?
For today's price to be fair in a discounted-cash-flow model, Oakridge International Ltd would have to grow free cash flow by +23.8 % per year for five years (discount rate 10.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +27.8 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of OAK use?
Our models discount Oakridge International Ltd at 10.3 %: a base by market capitalisation (nano), damped by beta 1.34, country premium for Australia. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Oakridge International Ltd that is +23.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.3 %) and the same formula as our fair value.
How much growth has Oakridge International Ltd (OAK) delivered so far?
Over the past 5 years revenue at Oakridge International Ltd grew +27.8 % a year. The price currently implies free-cash-flow growth of +23.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Oakridge International Ltd (OAK) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into Oakridge International Ltd (+23.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Oakridge International Ltd (OAK)?
The free-cash-flow yield on the price is 1.53 %: that much free cash flow Oakridge International Ltd produces per unit of market value. When it exceeds the discount rate of our models (10.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Oakridge International Ltd (OAK)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Oakridge International Ltd it is A$0.0480 per share (as of Nov 8, 2026), against a price of A$0.0610. It is the blended result of 17 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Oakridge International Ltd stock overvalued or undervalued in 2026?
As of Nov 8, 2026, OAK trades above its calculated fair value: price A$0.0610, fair value A$0.0480, a gap of about −21% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of OAK?
No. The price is what the market pays today (A$0.0610); the fair value is what the company's own numbers justify (A$0.0480). For Oakridge International Ltd the two are A$0.0130 per share apart. That gap is exactly why we show both numbers side by side.
How much is Oakridge International Ltd worth?
The market values Oakridge International Ltd at about A$2.0M (market capitalisation, as of Nov 8, 2026). Per share that is A$0.0610; our models calculate a fair value of A$0.0480 per share.
What do the bullish and bearish scenarios say about OAK?
Our models span a range for Oakridge International Ltd: cautious scenario A$0.0400, base A$0.0480, optimistic A$0.0640 per share (as of Nov 8, 2026, price A$0.0610). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Oakridge International Ltd (OAK)?
Balance-sheet figures for Oakridge International Ltd (as of Nov 8, 2026): return on equity 9.7%. They feed the Quality Score of 55/100, which measures business quality independently of the share price.
How far is OAK from its 52-week high?
Oakridge International Ltd trades at A$0.0610, about 39% below its 52-week high of A$0.1000 and 2% above the low of A$0.0600 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.0480 is for.
Which stocks are comparable to Oakridge International Ltd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Oakridge International Ltd stock attractive at the current price?
The data as of Nov 8, 2026: price A$0.0610, calculated fair value A$0.0480 (−21%), Quality Score 55/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of OAK calculated?
We run Oakridge International Ltd through 17 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of A$0.0480 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Oakridge International Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Oakridge International Ltd (OAK)?
The closing price on Nov 9, 2026 was A$0.0610. Our model-based fair value is A$0.0480, about 21% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Oakridge International Ltd right now?
Solid but not exceptional quality (55/100) and above fair value, neither a clear bargain nor a standout compounder. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Oakridge International Ltd
How large is the market capitalisation of Oakridge International Ltd (OAK)?
The market capitalisation of Oakridge International Ltd is A$2.0M (≈ $1.3M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Oakridge International Ltd (OAK)?
The price-to-sales ratio of Oakridge International Ltd is 0.74 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Oakridge International Ltd (OAK)?
The net margin of Oakridge International Ltd is 3.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Oakridge International Ltd (OAK)?
The return on equity (ROE) of Oakridge International Ltd is 9.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Oakridge International Ltd (OAK)?
On an EBIT basis the return on assets of Oakridge International Ltd is −32.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Oakridge International Ltd (OAK)?
The operating margin of Oakridge International Ltd is −2.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Oakridge International Ltd (OAK)?
Revenue at Oakridge International Ltd is growing +24.7% versus a year earlier (3y avg +41.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net cash does Oakridge International Ltd (OAK) hold?
Oakridge International Ltd holds more cash than debt, A$542K net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Oakridge International Ltd in the live analysis
One click puts Oakridge International Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 8, 2026